Patents-Review.com
ClassID:

21163 ⎘

A61K2039/5152 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Animal cells Tumor cells

Recent Application in this class:
#1
20260027193
2026-01-29

COMPOSITION THAT INCLUDES CANCER CELLS AND THAT IS ADMINISTERED BY A SYRINGE

 #2
20260000745
2026-01-01

COMPOSITION FOR PREVENTING OR TREATING CANCER, AND METHOD FOR PREVENTING OR TREATING CANCER BY USING SAME, HAVING ABSCOPAL EFFECT

 #3
20250333710
2025-10-30

GENOME EDITED CANCER CELL VACCINES

 #4
20250332235
2025-10-30

BREAST CANCER TUMOR CELL VACCINES

 #5
20250312315
2025-10-09

CANCER VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

 #6
20250302931
2025-10-02

COLORECTAL CANCER TUMOR CELL VACCINES

 #7
20250242006
2025-07-31

DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE

 #8
20250195648
2025-06-19

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

 #9
20250186568
2025-06-12

CANCER VACCINES AND METHODS OF USE THEREOF

 #10
20250172563
2025-05-29

MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER

 #11
20250134977
2025-05-01

TUMOR CELL VACCINES

 #12
20250108101
2025-04-03

Non-Oncolytic Virus Infected Dead Cancer Cell Vaccine

 #13
20240398865
2024-12-05

TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF

 #14
20240316103
2024-09-26

COMPOSITIONS AND METHODS OF TREATING PLASMA CELL DISORDERS INCLUDING MULTIPLE MYELOMA WITH A VACCINE COMPOSITION AND MYELOMA-SPECIFIC CAR-T CELLS

 #15
20240293458
2024-09-05

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF

 #16
20240226256
2024-07-11

Combination Therapy Tumour Cell Vaccine

 #17
20240226255
2024-07-11

COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS

 #18
20240207381
2024-06-27

BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF

 #19
20240158801
2024-05-16

STING DEPENDENT ADJUVANTS

 #20
20240156930
2024-05-16

TUMOR VACCINE BASED ON TUMOR-DERIVED MICROPARTICLES, AND PREPARATION METHOD AND USE THEREOF

 #21
20240148855
2024-05-09

CANCER VACCINE AND METHOD OF USE THEREOF

 #22
20240131130
2024-04-25

COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS

 #23
20240123045
2024-04-18

NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS

 #24
20240115676
2024-04-11

SILICIFIED TUMOR CELL COMPOSITIONS AND METHODS

 #25
20240108704
2024-04-04

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION

 #26
20240050480
2024-02-15

Th1 vaccination priming for active immunotherapy

 #27
20230414733
2023-12-28

TUMOR CELL VACCINES

 #28
20230381314
2023-11-30

ATTENUATED CANCER CELLS AND METHODS RELATED THERETO

 #29
20230346901
2023-11-02

METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS

 #30
20230338525
2023-10-26

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

 #31
20230277640
2023-09-07

WHOLE-CELL CANCER VACCINES AND METHODS FOR SELECTION THEREOF

 #32
20230248812
2023-08-10

TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY

 #33
20230121878
2023-04-20

WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION THEREOF

 #34
20230054318
2023-02-23

PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

 #35
20230034174
2023-02-02

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS, AND IMMUNOTOXINS

 #36
20230031483
2023-02-02

INDIVIDUALIZED VACCINES FOR CANCER TREATMENT AND PREVENTION

 #37
20230000963
2023-01-05

TUMOR CELL VACCINES

 #38
20220378839
2022-12-01

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

 #39
20220313720
2022-10-06

TARGETED CANCER THERAPY

 #40
20220305100
2022-09-29

METHODS OF VACCINATION AND USE OF CD47 BLOCKADE

 #41
20220273792
2022-09-01

A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES

 #42
20220268775
2022-08-25

SOLUBLE PROGRAMMED CELL DEATH PROTEIN-1 AS A BIOMARKER IN CANCER PATIENTS

 #43
20220257761
2022-08-18

Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer

 #44
20220257737
2022-08-18

Tumor cell vaccines

 #45
20220242924
2022-08-04

C3D CELLULAR AND ACELLULAR VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER

 #46
20220226449
2022-07-21

IMMUNOGENIC COMPOSITIONS

 #47
20220185890
2022-06-16

LAG-3 binding members

 #48
20220184192
2022-06-16

A Composition for the Delivery of Biologically Active Agents and Uses Thereof

 #49
20220160852
2022-05-26

HUMAN VACCINE COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA

 #50
20220154219
2022-05-19

GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS

 #51
20220152169
2022-05-19

COLORECTAL CANCER TUMOR CELL VACCINES

 #52
20220133869
2022-05-05

BREAST CANCER TUMOR CELL VACCINES

 #53
20220133868
2022-05-05

TUMOR CELL VACCINES

 #54
20220133788
2022-05-05

BAFF THERAPY TO PROMOTE ANTI-TUMOR IMMUNITY

 #55
20220111044
2022-04-14

WHOLE CELL TUMOR VACCINES AND METHODS OF USE THEROF

 #56
20220096539
2022-03-31

SALT NANOPARTICLES AND COMPOSITIONS AND METHODS OF USE THEREOF

 #57
20220088134
2022-03-24

CD200AR LIGANDS FOR CANCER IMMUNOTHERAPY

 #58
20220041644
2022-02-10

Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application

 #59
20220023338
2022-01-27

COMPOSITIONS AND METHODS RELATED TO TUMOR CELL KILLERS AND VACCINES

 #60
20220008527
2022-01-13

Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof

 #61
20220008524
2022-01-13

VACCINATION WITH MICROVESICLES DERIVED FROM TUMOUR CELLS FOR CANCER TREATMENT

 #62
20210401955
2021-12-30

CD4 T cells provide antibody access to immunoprivileged tissue

 #63
20210360914
2021-11-25

PRODUCTION OF CELL-BASED VACCINES

 #64
20210346486
2021-11-11

COMBINATION CELL-BASED THERAPIES

 #65
20210315983
2021-10-14

VACCINATION WITH CANCER NEOANTIGENS

 #66
20210268087
2021-09-02

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-EXPRESSING CANCER CELL VACCINE AND METHODS OF USE FOR PRODUCING INTEGRATED IMMUNE RESPONSES

 #67
20210260086
2021-08-26

METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS

 #68
20210253707
2021-08-19

GM-CSF/CD40L VACCINE AND CHECKPOINT INHIBITOR COMBINATION THERAPY

 #69
20210252122
2021-08-19

TUMOR CELL VACCINES

 #70
20210236694
2021-08-05

INDUCTION OF ANTI-TUMORAL IMMUNE MICROENVIRONMENTS

 #71
20210236630
2021-08-05

METHODS OF ENHANCING IMMUNOGENICITY OF POORLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING ORAL YEAST BETA-GLUCANS

 #72
20210236610
2021-08-05

ALLOGENEIC TUMOR CELL VACCINE

 #73
20210220488
2021-07-22

Methods for treating cancers

 #74
20210214683
2021-07-15

METHODS FOR ISOLATING TUMOR-SPECIFIC IMMUNE CELLS FROM A SUBJECT FOR ADOPTIVE CELL THERAPY AND CANCER VACCINES

 #75
20210205428
2021-07-08

TUMOR CELL VACCINES

 #76
20210205233
2021-07-08

INJECTABLE CRYOGEL VACCINE DEVICES AND METHODS OF USE THEREOF

 #77
20210161979
2021-06-03

CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER

 #78
20210154291
2021-05-27

Immunostimulatory compositions, particles, and uses related thereto

 #79
20210154281
2021-05-27

CELL-BASED CANCER VACCINES AND CANCER THERAPIES

 #80
20210121548
2021-04-29

COMPOSITIONS FOR ACTIVE CELLULAR IMMUNOTHERAPY OF CANCER BY USING TUMOR CELLS KILLED BY HIGH HYDROSTATIC PRESSURE AND DENDRITIC CELLS

 #81
20210113675
2021-04-22

Dual-scale porous silica particle-based composition for preventing or treating cancer

 #82
20210113674
2021-04-22

COMPOSITIONS AND METHODS FOR MULTIPLEXED TUMOR VACCINATION WITH ENDOGENOUS GENE ACTIVATION

 #83
20210060146
2021-03-04

DENDRITIC CELL VACCINATION IN PARALLEL TO CHEMOTHERAPY

 #84
20210060145
2021-03-04

DENDRITIC CELL VACCINATION SEQUENTIAL TO CHEMOTHERAPY

 #85
20210054043
2021-02-25

Modulation of SLAMF6 splice variants for cancer therapy

 #86
20210030858
2021-02-04

METHODS AND MATERIALS FOR TREATING CANCER

 #87
20210000945
2021-01-07

VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES

 #88
20210000936
2021-01-07

Cancer vaccine compositions and methods of use thereof

 #89
20200345822
2020-11-05

Whole-cell tumor vaccine based on principle of extracellular trap and method of making same

 #90
20200345809
2020-11-05

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

 #91
20200338127
2020-10-29

Th1 vaccination priming for active immunotherapy

 #92
20200330596
2020-10-22

Allogeneic tumor cell vaccine

 #93
20200330573
2020-10-22

Bacteriologically-modified whole-cell tumor vaccine and method of making same

 #94
20200323904
2020-10-15

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

 #95
20200317764
2020-10-08

MODIFIED MRNA FOR MULTICELL TRANSFORMATION

 #96
20200276290
2020-09-03

Combination vaccine devices and methods of killing cancer cells

 #97
20200276287
2020-09-03

Immunogenic composition for the treatment of cancer

 #98
20200223933
2020-07-16

Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

 #99
20200222520
2020-07-16

Recombinant vaccinia virus and methods of use thereof

 #100
20200222519
2020-07-16

Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers

 #101
20200222450
2020-07-16

Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same

 #102
20200179447
2020-06-11

Autologous irradiated whole cell tumor vaccines lentivirally engineered to express CD80, IL-15 and IL-15 receptor alpha

 #103
20200147191
2020-05-14

CRYOPRESERVATION OF APOPTOTIC CANCER CELLS FOR USE IN IMMUNOTHERAPY AGAINST CANCER

 #104
20200113986
2020-04-16

GENOME EDITED CANCER CELL VACCINES

 #105
20200101109
2020-04-02

Compositions and methods for treating cancer with anti-CD33 immunotherapy

 #106
20200085947
2020-03-19

Vista modulators for diagnosis and treatment of cancer

 #107
20200085862
2020-03-19

Multifunctional linker technology containing an N4 group

 #108
20200061091
2020-02-27

Methods of inhibition of protein fucosylation in vivo using fucose analogs

 #109
20200009247
2020-01-09

DRUG COMBINATIONS

 #110
20200000905
2020-01-02

Heat shock protein-binding peptide compositions and methods of use thereof

 #111
20200000901
2020-01-02

DNA vector and transformed tumor cell vaccines

 #112
20200000896
2020-01-02

COMPOSITIONS AND METHODS OF TREATING CANCER

 #113
20190382503
2019-12-19

Oncofetal antigen binding proteins and related compositions and methods

 #114
20190365878
2019-12-05

PHARMACEUTICAL TREATMENTS FOR PREVENTING OR TREATING PANCREATIC CANCER

 #115
20190358291
2019-11-28

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

 #116
20190330344
2019-10-31

LAG-3 binding members

 #117
20190309297
2019-10-10

Methods and compositions for the treatment of cancer

 #118
20190290734
2019-09-26

Complexes of IL-15 and IL-15Ralpha and uses thereof

 #119
20190262443
2019-08-29

Therapeutic cancer vaccine

 #120
20190249192
2019-08-15

Cell for immunotherapy, including modified nucleic acid construct encoding Wilms tumor gene product

 #121
20190248889
2019-08-15

ANTI-LGR5 ANTIBODIES AND USES THEREOF

 #122
20190224292
2019-07-25

Methods of Augmenting Tumor Vaccine Efficacy through Endothelial Targeting

 #123
20190216909
2019-07-18

Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells

 #124
20190201514
2019-07-04

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

 #125
20190175706
2019-06-13

TUMOR VACCINE

 #126
20190144514
2019-05-16

C3D cellular and acellular vaccines for the prevention and treatment of cancer

 #127
20190117711
2019-04-25

Chimeric VSV virus compositions and methods of use thereof for treatment of cancer

 #128
20190091307
2019-03-28

PTPS-BASED VACCINES AGAINST CANCER

 #129
20190070278
2019-03-07

Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer

 #130
20190046624
2019-02-14

Whole-cell cancer vaccines and methods for selection thereof

 #131
20190038731
2019-02-07

Therapeutic cancer vaccine based on stress proteins rendered immunogenic

 #132
20190022200
2019-01-24

Cancer vaccine compositions and methods of using the same

 #133
20190016816
2019-01-17

Oncofetal antigen binding proteins and related compositions and methods

 #134
20190016772
2019-01-17

GM-CSF and IL-4 conjugates, compositions, and methods related thereto

 #135
20190015493
2019-01-17

ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN

 #136
20190015488
2019-01-17

METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST

 #137
20190000967
2019-01-03

Vector co-expressing vaccine and costimulatory molecules

 #138
20180360955
2018-12-20

Vector co-expressing vaccine and costimulatory molecules

 #139
20180360879
2018-12-20

Agents and compositions for eliciting an immune response

 #140
20180311269
2018-11-01

Targeted cancer therapy

 #141
20180296654
2018-10-18

Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells

 #142
20180280438
2018-10-04

Compositions and methods for treating cancer with anti-CD33 immunotherapy

 #143
20180280423
2018-10-04

Compositions and methods for combating drug-resistant cancers

 #144
20180243231
2018-08-30

Injectable Cryogel Vaccine Devices and Methods of Use Thereof

 #145
20180237487
2018-08-23

LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN

 #146
20180228775
2018-08-16

METHODS OF TREATING CANCER

 #147
20180195087
2018-07-12

Cell for immunotherapy, including modified nucleic acid construct encoding Wilms tumor gene product

 #148
20180185463
2018-07-05

Allogeneic tumor cell vaccine

 #149
20180162943
2018-06-14

GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy

 #150
20180153978
2018-06-07

TUMORS EXPRESSING IgG1 Fc INDUCE ROBUST CD8 T CELL RESPONSES

 #151
20180125956
2018-05-10

Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer

 #152
20180117145
2018-05-03

Immunostimulatory compositions, particles, and uses related thereto

 #153
20180085448
2018-03-29

DNA vector and transformed tumor cell vaccines

 #154
20180078611
2018-03-22

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

 #155
20180042850
2018-02-15

Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity

 #156
20180030457
2018-02-01

Protein expression enhancer sequences and use thereof

 #157
20180008686
2018-01-11

Autologous tumor vaccines and methods

 #158
20180002720
2018-01-04

CELL FOR USE IN IMMUNOTHERAPY WHICH CONTAINS MODIFIED NUCLEIC ACID CONSTRUCT ENCODING WILMS TUMOR GENE PRODUCT OR FRAGMENT THEREOF, METHOD FOR PRODUCING SAID CELL, AND SAID NUCLEIC ACID CONSTRUCT

 #159
20170369587
2017-12-28

Bispecific tetravalent antibodies and methods of making and using thereof

 #160
20170348403
2017-12-07

Adherent cancer cell line expressing a hematological tumor antigen

 #161
20170348388
2017-12-07

ADJUVANTS USEFUL FOR STIMULATION OF IMMUNITY TO TUMOR ENDOTHELIAL CELLS

 #162
20170326214
2017-11-16

CD4 T cells provide antibody access to immunoprivileged tissue

 #163
20170320966
2017-11-09

Humanized monoclonal antibody and uses thereof

 #164
20170304421
2017-10-26

Anti-mutated KRAS T cell receptors

 #165
20170290899
2017-10-12

Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells

 #166
20170281743
2017-10-05

Th1 vaccination priming for active immunotherapy

 #167
20170275629
2017-09-28

Methods and compositions for the treatment of cancer

 #168
20170258883
2017-09-14

Protease-engineered Cancer Cell Spheres as an Immunotherapy to Treat Cancer and non-Cancer Diseases

 #169
20170233471
2017-08-17

Anti-LGR5 antibodies and uses thereof

 #170
20170232090
2017-08-17

Multi-indication mRNA cancer immunotherapy

 #171
20170232086
2017-08-17

Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer

 #172
20170226171
2017-08-10

ADENOCARCINOMA ANTIGENIC DETERMINANTS AND METHODS

 #173
20170224793
2017-08-10

TUMOR IMMUNITY

 #174
20170224732
2017-08-10

Discovery of regulatory T cells programmed to suppress an immune response

 #175
20170202949
2017-07-20

DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE

 #176
20170182138
2017-06-29

In situ antigen-generating cancer vaccine

 #177
20170175083
2017-06-22

Isolation and use of solid tumor stem cells

 #178
20170168054
2017-06-15

Methods and systems for predicting response to immunotherapies for treatment of cancer

 #179
20170157231
2017-06-08

Therapeutic cancer vaccine

 #180
20170151310
2017-06-01

Complexes of IL-15 and IL-15Ralpha and uses thereof

 #181
20170136109
2017-05-18

DNA vector and transformed tumor cell vaccines

 #182
20170113061
2017-04-27

METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES

 #183
20170106067
2017-04-20

COMBINATORIAL IMMUNOTHERAPY FOR PANCREATIC CANCER TREATMENT

 #184
20170095546
2017-04-06

Vaccination with immuno-isolated cells producing an immunomodulator

 #185
20170088595
2017-03-30

Lectin compositions and methods for modulating an immune response to an antigen

 #186
20170087234
2017-03-30

Vaccination with immuno-isolated cells producing an immunomodulator

 #187
20170073418
2017-03-16

Bispecific tetravalent antibodies and methods of making and using thereof

 #188
20170042995
2017-02-16

Combination vaccine devices and methods of killing cancer cells

 #189
20170042993
2017-02-16

Multi-indication mRNA cancer immunotherapy

 #190
20170035790
2017-02-09

Methods of inhibition of protein fucosylation in vivo using fucose analogs

 #191
20170000867
2017-01-05

Vaccine compositions and methods for restoring NKG2D pathway function against cancers

 #192
20160375116
2016-12-29

Method for treating Stage IV melanoma

 #193
20160361400
2016-12-15

DNA vector and transformed tumor cell vaccines

 #194
20160345574
2016-12-01

Cryoprotected, frozen recombinant cancer cells

 #195
20160310582
2016-10-27

Id-protein targeted tumor cell vaccine

 #196
20160296610
2016-10-13

THERAPEUTIC CANCER VACCINE BASED ON STRESS PROTEINS RENDERED IMMUNOGENIC

 #197
20160296572
2016-10-13

Chimeric VSV virus compositions and methods of use thereof for treatment of cancer

 #198
20160263207
2016-09-15

Therapeutic composition for treatment of glioblastoma

 #199
20160228524
2016-08-11

AUTOLOGOUS CANCER CELL VACCINE

 #200
20160213764
2016-07-28

COMPOSITE TISSUE CANCER VACCINE

 #201
20160206717
2016-07-21

STIMULATION OF IMMUNITY TO ENDOTHELIAL CELLS, ENDOTHELIAL-LIKE CELLS, AND INTRATUMOR VASCULAR CHANNELS DERIVED FROM TUMOR TISSUE

 #202
20160193313
2016-07-07

IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA

 #203
20160175416
2016-06-23

Allogeneic tumor cell vaccination

 #204
20160175415
2016-06-23

Methods and compositions using for enhancing immunogenicity by prime boost

 #205
20160151472
2016-06-02

Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer

 #206
20160144010
2016-05-26

Method of vaccinating using allogeneic cells

 #207
20160136270
2016-05-19

Vaccine comprising allogeneic T-cells

 #208
20160129097
2016-05-12

METHOD OF PROCESSING A VETERINARY TUMOR VACCINE AND A VETERINARY TUMOR VACCINE PROCESSING KIT

 #209
20160051653
2016-02-25

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

 #210
20160046687
2016-02-18

GM-CSF and IL-4 conjugates, compositions, and methods related thereto

 #211
20160045583
2016-02-18

Tumor vaccine

 #212
20160045569
2016-02-18

ENDOGENOUS VACCINE FOR CANCER AND INFECTIOUS DISEASES

 #213
20160022808
2016-01-28

Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus

 #214
20160017293
2016-01-21

INDIVIDUALIZED HIGH PURITY HEPATOCELLULAR CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME

 #215
20160015805
2016-01-21

DRUG COMBINATIONS

 #216
20160015779
2016-01-21

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

 #217
20150374809
2015-12-31

Tumor vaccines and methods of use thereof

 #218
20150361449
2015-12-17

Reagent for gene-drug therapeutics

 #219
20150352200
2015-12-10

Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells

 #220
20150343040
2015-12-03

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

 #221
20150297715
2015-10-22

Lectin compositions and methods for modulating an immune response to an antigen

 #222
20150265701
2015-09-24

Immunomodulating compositions and uses therefor

 #223
20150252331
2015-09-10

Method for inducing fusion of dendritic cell with tumour cell

 #224
20150184130
2015-07-02

Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer

 #225
20150174224
2015-06-25

Materials and Methods for Eliciting Targeted Antibody Responses In Vivo

 #226
20150132285
2015-05-14

Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells

 #227
20150125485
2015-05-07

Methods and compositions using listeria for enhancing immunogenicity by prime boost

 #228
20150093416
2015-04-02

AUTOLOGOUS TUMOR VACCINES AND METHODS

 #229
20150086639
2015-03-26

Tumor vaccine and method for producing the same

 #230
20150071987
2015-03-12

IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO

 #231
20150064219
2015-03-05

Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells

 #232
20150017193
2015-01-15

RAB6KIFL/KIF20A epitope peptide and vaccines containing the same

 #233
20150010613
2015-01-08

Compositions and methods for cancer immunotherapy

 #234
20140348846
2014-11-27

Anti-HLA class-IB antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (IVIG) useful as therapeutic IVIG mimetics and methods of their use

 #235
20140341982
2014-11-20

Vaccination with immuno-isolated cells producing an immunomodulator

 #236
20140341978
2014-11-20

Cancer immunotherapy

 #237
20140314814
2014-10-23

Antigen presenting cancer vaccine

 #238
20140242118
2014-08-28

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

 #239
20140227327
2014-08-14

Injectable cryogel vaccine devices and methods of use thereof

 #240
20140193488
2014-07-10

In situ antigen-generating cancer vaccine

 #241
20140179004
2014-06-26

Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct

 #242
20140141045
2014-05-22

Allogeneic tumor cell vaccination

 #243
20140120124
2014-05-01

Cell capable of expressing exogenous GITR ligand

 #244
20140105912
2014-04-17

VISTA modulators for diagnosis and treatment of cancer

 #245
20140099307
2014-04-10

Dendritic cell co-stimulatory molecules

 #246
20140093889
2014-04-03

Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases

 #247
20140072597
2014-03-13

Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

 #248
20140037692
2014-02-06

Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

 #249
20140037644
2014-02-06

Method for treating cancer using an antibody that inhibits notch4 signaling

 #250
20130330363
2013-12-12

Method of stimulating an immune response

 #251
20130323300
2013-12-05

Therapeutic composition for treatment of glioblastoma

 #252
20130302376
2013-11-14

Allogeneic cancer cell-based immunotherapy

 #253
20130302341
2013-11-14

Therapeutic and diagnostic applications targeting TNK-1

 #254
20130189310
2013-07-25

Autologous cancer cell vaccine

 #255
20130177625
2013-07-11

Immunogenic compositions and methods for treating neoplasia

 #256
20130129784
2013-05-23

Methods of inhibition of protein fucosylation in vivo using fucose analogs

 #257
20130115243
2013-05-09

Virally infected hematopoietic cells and uses thereof

 #258
20130064857
2013-03-14

METHODS AND MATERIALS FOR MAKING AND USING VACCINES

 #259
20130064856
2013-03-14

UNIVERSAL TUMOR CELL VACCINE FOR ANTI CANCER THERAPEUTIC AND PROPHYLACTIC UTILIZATION

 #260
20130052215
2013-02-28

TUMOR VACCINE

 #261
20130028835
2013-01-31

Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses

 #262
20130022600
2013-01-24

PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof

 #263
20130017222
2013-01-17

Human prostate cell lines in cancer treatment

 #264
20130011438
2013-01-10

Means And Methods For Active Cellular Immunotherapy Of Cancer By Using Tumor Cells Killed By High Hydrostatic Pressure and Dendritic Cells

 #265
20120321645
2012-12-20

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

 #266
20120315290
2012-12-13

INHIBITORS OF LL-37 MEDIATED IMMUNE REACTIVITY TO SELF NUCLEIC ACIDS

 #267
20120308607
2012-12-06

MUTZ-3 dendritic cells

 #268
20120308605
2012-12-06

Pharmaceutical composition of killed cells with substantially retained immunogenicity

 #269
20120295350
2012-11-22

Prospective Identification and Characterization of Breast Cancer Stem Cells

 #270
20120282215
2012-11-08

Vaccination of Cancer Patients

 #271
20120251579
2012-10-04

COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE

 #272
20120225043
2012-09-06

Enhancement of immune responses by 4-1 BB-binding agents

 #273
20120213785
2012-08-23

ANTI-NOTCH3 AGONIST ANTIBODIES AND THEIR USE IN THE TREATMENT OF NOTCH3-RELATED DISEASES

 #274
20120213773
2012-08-23

Binding domain-immunoglobulin fusion proteins

 #275
20120171240
2012-07-05

Immunostimulatory compositions and methods

 #276
20120164099
2012-06-28

USE OF HUMAN PROSTATE CELL LINES IN CANCER TREATMENT

 #277
20120151611
2012-06-14

Method of producing an antibody using a cancer cell

 #278
20120094952
2012-04-19

Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting

 #279
20120082687
2012-04-05

Use of cell adhesion inhibitor for the mobilization of antigen presenting cells and immune cells in a cell mixture (AIM) from the peripheral blood and methods of use

 #280
20120065385
2012-03-15

DENDRITIC CELL CO-STIMULATORY MOLECULES

 #281
20120065374
2012-03-15

DENDRITIC CELL CO-STIMULATORY MOLECULES

 #282
20120027858
2012-02-02

Methods and Compositions for Managing Cancer Cell Growth

 #283
20120027685
2012-02-02

Determining the capability of a test compound to affect solid tumor stem cells

 #284
20110318387
2011-12-29

IMMUNIZATION METHOD USING CANCER CELLS

 #285
20110287057
2011-11-24

Cancer Treatment

 #286
20110280911
2011-11-17

Cancer vaccine compositions and methods of using the same

 #287
20110268767
2011-11-03

USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES

 #288
20110262471
2011-10-27

RAB6KIFL/KIF20A epitope peptide and vaccines containing the same

 #289
20110262389
2011-10-27

Tumor-derived Biological Antigen Presenting Particles

 #290
20110256167
2011-10-20

IMMUNOSTIMULATING SAPONINS FOR USE IN SITU TUMOR-DESTRUCTION THERAPY

 #291
20110250233
2011-10-13

Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

 #292
20110250230
2011-10-13

Cell capable of expressing exogenous GITR ligand

 #293
20110250229
2011-10-13

Allogeneic cancer cell-based immunotherapy

 #294
20110243951
2011-10-06

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS AND IMMUNOTOXINS

 #295
20110229502
2011-09-22

Ablative immunotherapy

 #296
20110223164
2011-09-15

BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

 #297
20110206735
2011-08-25

Tumorigenic CancerStemCells, Methods of Isolating and Using the Same

 #298
20110206675
2011-08-25

Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases

 #299
20110182939
2011-07-28

Farnesoid-X-receptor antagonist as a vaccine adjuvant

 #300
20110171211
2011-07-14

Heat shock protein GP96 vaccination and methods of using same